Abstract
This report analyzes the worldwide markets for DNA Probes-based Diagnostics in
Millions of US$. The specific end-use segments discussed are Infectious
Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, and
Molecular HLA (Human Leukocyte Antigen) Typing. The report provides separate
comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and
Latin America. Annual forecasts are provided for each region for the period of
2000 through 2010. The report profiles 46 companies including many key and
niche players worldwide such as Abbott Laboratories, Affymetrix Inc., Applied
Biosystems Group, Bayer Diagnostics, Becton Dickinson & Company, Beckman
Coulter, bioMerieux, Biogenex Laboratories, Celera Genomics, Digene
Corporation, Gen-Probe Inc, Genzyme Corp, MP Biomedicals, Roche Diagnostics,
and Tm Bioscience. Market data and analytics are derived from primary and
secondary research. Company profiles are mostly extracted from URL research
and reported select online sources.
View Cart
